Symbol="MESO"
AssetType="Common Stock"
Name="Mesoblast Ltd"
Description="Mesoblast Limited, a biopharmaceutical company, develops and markets allogeneic cellular drugs. The company is headquartered in Melbourne, Australia."
CIK="1345099"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, AU"
FiscalYearEnd="June"
LatestQuarter="2023-03-31"
MarketCapitalization="636282000"
EBITDA="-67471000"
PERatio="0.385"
PEGRatio="0"
BookValue="3.275"
DividendPerShare="0"
DividendYield="0"
EPS="10.16"
RevenuePerShareTTM="0.055"
ProfitMargin="0"
OperatingMarginTTM="-9.23"
ReturnOnAssetsTTM="-0.0657"
ReturnOnEquityTTM="-0.163"
RevenueTTM="7586000"
GrossProfitTTM="-53361000"
DilutedEPSTTM="10.16"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.036"
AnalystTargetPrice="10.5"
TrailingPE="0.385"
ForwardPE="833.33"
PriceToSalesRatioTTM="56.79"
PriceToBookRatio="0.93"
EVToRevenue="62.57"
EVToEBITDA="-7.87"
Beta="2.434"
num_52WeekHigh="4.62"
num_52WeekLow="2.53"
num_50DayMovingAverage="3.648"
num_200DayMovingAverage="3.318"
SharesOutstanding="162732000"
DividendDate="None"
ExDividendDate="None"
symbol="MESO"
open="3.87"
high="3.99"
low="3.81"
price="3.91"
volume="165214.00"
latest_trading_day="2023-07-07"
previous_close="3.85"
change="0.06"
change_percent="1.5584%"
aroon_positive_momentum_days="62"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="62"
Volume_recent_avg="138392"
Change_recent_avg="-0.01"
Delta_recent_avg="0.14"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.37"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="62"
Aroon_momentum_negative="38"
image_negative_thumbnail_id_1="104"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0072.jpeg"
image_negative_thumbnail_id_2="126"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0050.jpeg"
image_neutral_thumbnail_id_1="527"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_neutral_thumbnail_id_2="561"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0038.jpeg"
image_positive_thumbnail_id_1="647"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0061.jpeg"
image_positive_thumbnail_id_2="629"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0079.jpeg"
image_professor_thumbnail_id_1="1197"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
